| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI)
MRVI Technical Analysis
5
| As on 9th Jun 2023 MRVI STOCK Price closed @ 13.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.51 & Strong Sell for SHORT-TERM with Stoploss of 33.77 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRVISTOCK Price
| Open | 13.49 | Change | Price | % |
| High | 13.49 | 1 Day | -0.48 | -3.55 |
| Low | 12.94 | 1 Week | -0.02 | -0.15 |
| Close | 13.03 | 1 Month | -0.32 | -2.40 |
| Volume | 1023201 | 1 Year | -28.31 | -68.48 |
| 52 Week High 42.93 | 52 Week Low 12.09 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRVI Daily Charts |
MRVI Intraday Charts |
Whats New @ Bazaartrend |
MRVI Free Analysis |
|
|
MRVI Important Levels Intraday
| RESISTANCE | 14.09 |
| RESISTANCE | 13.75 |
| RESISTANCE | 13.54 |
| RESISTANCE | 13.33 |
| SUPPORT | 12.73 |
| SUPPORT | 12.52 |
| SUPPORT | 12.31 |
| SUPPORT | 11.97 |
MRVI Forecast May 2024
| 4th UP Forecast | 38.12 |
| 3rd UP Forecast | 30.07 |
| 2nd UP Forecast | 25.1 |
| 1st UP Forecast | 20.13 |
| 1st DOWN Forecast | 5.93 |
| 2nd DOWN Forecast | 0.96 |
| 3rd DOWN Forecast | -4.01 |
| 4th DOWN Forecast | -12.06 |
MRVI Weekly Forecast
| 4th UP Forecast | 19.74 |
| 3rd UP Forecast | 17.59 |
| 2nd UP Forecast | 16.26 |
| 1st UP Forecast | 14.93 |
| 1st DOWN Forecast | 11.13 |
| 2nd DOWN Forecast | 9.80 |
| 3rd DOWN Forecast | 8.47 |
| 4th DOWN Forecast | 6.32 |
MRVI Forecast2024
| 4th UP Forecast | 74.52 |
| 3rd UP Forecast | 54.8 |
| 2nd UP Forecast | 42.61 |
| 1st UP Forecast | 30.42 |
| 1st DOWN Forecast | -4.36 |
| 2nd DOWN Forecast | -16.55 |
| 3rd DOWN Forecast | -28.74 |
| 4th DOWN Forecast | -48.46 |
Maravai LifeSciences Holdings Inc ( NASDAQ USA Symbol : MRVI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRVI Business Profile
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry, immunofluorescence, and glycobiology. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service